Financings in Brief: Atrix Laboratories
This article was originally published in The Gray Sheet
Executive Summary
Atrix Laboratories: Files registration statement for an offering of 2.5 mil. shares to be underwritten by Montgomery Securities and Cruttenden Roth. Atrix, which is developing dental and medical products based on its Atrigel biodegradable polymer technology, recently gained 510(k) clearance from FDA for its first product, the Atrisorb barrier for guided tissue generation ("The Gray Sheet" April 1, In Brief)...